Chromosome Transplantation: Opportunities and Limitations

Angela La Grua,Ilaria Rao,Lucia Susani,Franco Lucchini,Elena Raimondi,Paolo Vezzoni,Marianna Paulis

DOI: https://doi.org/10.3390/cells13080666

IF: 6

2024-04-11

Cells

Abstract:There are thousands of rare genetic diseases that could be treated with classical gene therapy strategies such as the addition of the defective gene via viral or non-viral delivery or by direct gene editing. However, several genetic defects are too complex for these approaches. These "genomic mutations" include aneuploidies, intra and inter chromosomal rearrangements, large deletions, or inversion and copy number variations. Chromosome transplantation (CT) refers to the precise substitution of an endogenous chromosome with an exogenous one. By the addition of an exogenous chromosome and the concomitant elimination of the endogenous one, every genetic defect, irrespective of its nature, could be resolved. In the current review, we analyze the state of the art of this technique and discuss its possible application to human pathology. CT might not be limited to the treatment of human diseases. By working on sex chromosomes, we showed that female cells can be obtained from male cells, since chromosome-transplanted cells can lose either sex chromosome, giving rise to 46,XY or 46,XX diploid cells, a modification that could be exploited to obtain female gametes from male cells. Moreover, CT could be used in veterinary biology, since entire chromosomes containing an advantageous locus could be transferred to animals of zootechnical interest without altering their specific genetic background and the need for long and complex interbreeding. CT could also be useful to rescue extinct species if only male cells were available. Finally, the generation of "synthetic" cells could be achieved by repeated CT into a recipient cell. CT is an additional tool for genetic modification of mammalian cells.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to treat complex genetic defect diseases through Chromosome Transplantation (CT) technology. Specifically, these genetic defects include aneuploidy, intrachromosomal and interchromosomal rearrangements, large - fragment deletions or inversions, and copy - number variations, etc. These defects usually cannot be effectively resolved by traditional gene - therapy strategies such as gene addition or direct gene editing. The paper explores the potential application of CT technology in human pathology and its potential uses in other fields, such as sex conversion, favorable gene transfer in veterinary biology, and the restoration of extinct species.

The core of CT technology lies in precisely replacing the endogenous chromosomes carrying genetic defects with normal exogenous chromosomes, thereby forming genetically correct diploid cells. This technology is expected to be used not only for the treatment of rare genetic diseases but also in a broader range of biomedical research fields.